Skip to main content
Log in

Practical Aspects of Drug Treatment in Elderly Patients with Mobility Problems

  • Review Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

Elderly people with impaired mobility frequently experience difficulty with medication administration and compliance. Many medications are dispensed in packages or in containers which are difficult to access by older people with disabilities. Attending a medical centre, activating an inhaler, applying eyedrops or opening medication containers can prove major obstacles to medication compliance for older people with impaired function. Assessment of each patient’s ability to physically comply with medication regimens by the physician is therefore recommended. Contact with the care giver or support person should also be made where appropriate. Compliance aids such as some calendar packages for medications, metered dose inhalers (MDIs) or eyedrop aids should be prescribed where indicated. Because of their close contact with many elderly patients when dispensing, pharmacists can also play an important role in ensuring adherence with medication regimens.

Some medications may improve mobility as seen in the treatment of Parkinson’s disease whereas other medications such as phenothiazines may impair mobility and contribute to falls. Several drug classes including antipsychotics, antidepressants, antihypertensives and benzodiazepines have been recognised as having an association with falls and impaired mobility. Multiple medications have also been found to be a risk factor in falls. Medications should be reviewed regularly and rationalised where possible. If mobility problems or unexplained falls are occurring, medications should be closely scrutinized as they may be responsible.

Where possible, domiciliary visits for older people should be undertaken by health professionals as they often provide critical information about a patient’s functional status, their medication compliance and their ability to cope at home. Emphasis must be placed on older people maintaining their independence and mobility. This is best achieved through a multidisciplinary approach.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Morrow D, Leirer V, Sheikh J. Adherence and medication instructions; review and recommendations. J Am Geriatr Soc 1988; 36; 1147–60

    PubMed  CAS  Google Scholar 

  2. Burns JMA, Sneddon I, Lovell M, et al. Elderly patients and their medication: a post-discharge follow-up study. Age Ageing 1992; 21: 178–81

    Article  PubMed  CAS  Google Scholar 

  3. Trewin VF, Lawrence CJ, Veitch GBA, et al. Comparing dispensing doctors and community pharmacists by assessment of drug problems in the elderly admitted to hospital. Pharm J 1996; 257: 158–60

    Google Scholar 

  4. O’Connell MB, Johnson JF. Evaluation of medication knowledge in elderly patients. Ann Pharmacother 1992; 26: 919–21

    PubMed  Google Scholar 

  5. Royal Pharmaceutical Society. Medicines, ethics and practice: a guide for pharmacists. No.4. London: Pharmaceutical Press, 1990

    Google Scholar 

  6. McIntire MS, Angle CR, Sathees K, et al. Safety packaging: what does the public think? Am J Public Health 1977; 67: 169–71

    Article  PubMed  CAS  Google Scholar 

  7. Atkin PA, Finnegan TP, Ogle SJ, et al. Functional ability of patients to manage medication packaging: a survey of geriatric inpatients. Age Ageing 1994; 23: 113–6

    Article  PubMed  CAS  Google Scholar 

  8. Fleming BB, Pulliam CC, Perfetto EM, et al. Medication use by home health patients. J Geriatr Drag Ther 1993; 73: 33–46

    Google Scholar 

  9. Sherman FT, Warach JD, Libow LS. Child-resistant containers for the elderly? JAMA 1979; 241: 1001–2

    Article  PubMed  CAS  Google Scholar 

  10. Ware GJ, Holford NHG, Davison JG, et al. Unit dose calendar packaging and elderly patient compliance. NZ Med J 1991; 104: 495–7

    CAS  Google Scholar 

  11. Winfield AJ, Jessiman D, Williams A, et al. A study of the causes of non-compliance by patients prescribed eyedrops. Br J Ophthalmol 1990; 74: 477–80

    Article  PubMed  CAS  Google Scholar 

  12. Allen SC, Prior A. What determines whether an elderly patient can use a metered dose inhaler correctly? Br J Dis Chest 1986; 80: 45–9

    Article  PubMed  CAS  Google Scholar 

  13. Armitage JM, Williams SJ. Inhaler technique in the elderly. Age Ageing 1988; 17: 275–8

    Article  PubMed  CAS  Google Scholar 

  14. Connolly MJ. Inhaler technique of elderly patients: comparison of metered-dose inhalers and large volume spacer devices. Age Ageing 1995; 24: 190–2

    Article  PubMed  CAS  Google Scholar 

  15. Gray SL, Williams DM, Pulliam CC, et al. Characteristics predicting incorrect metered-dose inhaler technique in older subjects. Arch Intern Med 1996: 156: 984–8

    Article  PubMed  CAS  Google Scholar 

  16. Chapman KR, Love L, Brubaker H. A comparison of breath-actuated and conventional metered-dose inhaler inhalation techniques in elderly subjects. Chest 1993; 104(5): 1332–7

    Article  PubMed  CAS  Google Scholar 

  17. Teale C, Jones A, Patterson CJ, et al. Community survey of home nebulizer technique by elderly people. Age Ageing 1995; 24: 276–7

    Article  PubMed  CAS  Google Scholar 

  18. Naylor DM, Oxley DV. Assessing the need for a domiciliary pharmaceutical service for elderly patients using a coding system to record and quantify data. Pharm J 1997; 258: 479–84

    Google Scholar 

  19. Hsia Der E, Rubenstein LZ, Choy GS. The benefits of in-home pharmacy evaluation for older persons. J Am Geriatr Soc 1997; 45: 211–4

    PubMed  CAS  Google Scholar 

  20. Hanlon JT, Schmader KE, Samsa GP, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992; 45: 1045–51

    Article  PubMed  CAS  Google Scholar 

  21. Samsa GP, Hanlon JT, Schmader KE, et al. A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validity. J Clin Epidemiol 1994; 47: 891–6

    Article  PubMed  CAS  Google Scholar 

  22. Schmader KE, Hanlon JT, Weinberger M, et al. Appropriateness of medication prescribing in ambulatory elderly patients. J Am Geriatr Soc 1994; 42: 1241–7

    PubMed  CAS  Google Scholar 

  23. Fitzgerald LS, Hanlon JT, Shelton PS, et al. Reliability of a modified medication appropriateness index in ambulatory older persons. Ann Pharmacother 1997; 31: 543–7

    PubMed  CAS  Google Scholar 

  24. Moore AA, Siu AL. Screening for common problems in ambulatory elderly: clinical confirmation of a screening instrument. Am J Med 1996; 100: 438–43

    Article  PubMed  CAS  Google Scholar 

  25. Fitten LJ, Coleman L, Siembieda DW, et al. Assessment of capacity to comply with medication regimens in older patients. J Am Geriatr Soc 1995; 43: 361–7

    PubMed  CAS  Google Scholar 

  26. Tinetti ME, Speechley M, Ginter SF. Risk factors for falls among elderly persons living in the community. N Engl J Med 1988; 319: 1701–7

    Article  PubMed  CAS  Google Scholar 

  27. Sorock GS, Shimkin EE. Benzodiazepine sedatives and the risk of falling in a community-dwelling elderly cohort. Arch Intern Med 1988; 148: 2441–4

    Article  PubMed  CAS  Google Scholar 

  28. Campbell AJ, Borrie MJ, Spears GF. Risk factors for falls in a community-based prospective study of people 70 years and older. J Gerontol 1989; 44: M112–7

    PubMed  CAS  Google Scholar 

  29. Ray WA, Griffin MR, Schaffner W, et al. Psychomotor drug use and the risk of hip fracture. N Engl J Med 1987; 316: 363–9

    Article  PubMed  CAS  Google Scholar 

  30. Ray WA, Griffin MR, Downey W. Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA 1989; 262: 3303–7

    Article  PubMed  CAS  Google Scholar 

  31. Herings RMC, Stricker BH, de Boer A, et al. Benzodiazepines and the risk of falling leading to femur fractures: dosage more important than elimination half-life. Arch Intern Med 1995; 155: 1801–7

    Article  PubMed  CAS  Google Scholar 

  32. Liu B, Anderson G, Mittmann N, et al. Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. Lancet 1998; 351: 1303–7

    Article  PubMed  CAS  Google Scholar 

  33. Thapa PB, Gideon P, Cost TW, et al. Antidepressants and the risk of falls among nursing home residents. N Engl J Med 1998; 339: 875–82

    Article  PubMed  CAS  Google Scholar 

  34. Collins KJ, Exton-Smith AN, James MH, et al. Functional changes in autonomic nervous responses with ageing. Age Ageing 1980; 9: 17–24

    Article  PubMed  CAS  Google Scholar 

  35. Granek E, Baker SP, Abbey H, et al. Medications and diagnoses in relation to falls in a long-term care facility. J Am Geriatr Soc 1987; 35: 503–11

    PubMed  CAS  Google Scholar 

  36. Cumming RG, Miller JP, Kelsey JL, et al. Medications and multiple falls in elderly people: the St Louis OASIS study. Age Ageing 1991; 20: 455–61

    Article  PubMed  CAS  Google Scholar 

  37. Prudham D and Evans JG. Factors associated with falls in the elderly: a community study. Age Ageing 1981; 10, 141–6

    Article  PubMed  CAS  Google Scholar 

  38. Taggart HM. Do drugs affect the risk of hip fracture in elderly women? J Am Geriatr Soc 1988; 36(11): 1006–10

    PubMed  CAS  Google Scholar 

  39. Avorn J, Bohn RL, Mogun H, et al. Neuroleptic drug exposure and treatment of parkinsonism in the elderly: a case-control study. Am J Med 1995; 99: 48–54

    Article  PubMed  CAS  Google Scholar 

  40. Grimes JD, Hassan MN, Preston DN. Adverse neurologic effects of metoclopramide. Can Med Assoc J 1982; 126(1): 23–5

    PubMed  CAS  Google Scholar 

  41. Thapa PB, Meador KG, Gideon P, et al. Effects of antipsychotic withdrawal in elderly nursing home residents. J Am Geriatr Soc 1994; 42: 280–6

    PubMed  CAS  Google Scholar 

  42. Olesen LL, Jensen TS. Prevention and management of drug-induced peripheral neuropathy. Drag Saf 1991; 6(4): 302–14

    Article  CAS  Google Scholar 

  43. Owens NJ, Silliman RA, Fretwell MD. The relationship between comprehensive functional assessment and optimal pharmacotherapy in the older patient. DICP 1989; 23(11): 847–54

    PubMed  CAS  Google Scholar 

  44. Hardman JG, Limbird LE, editors. Goodman and Gilman’s The pharmacological basis of therapeutics. New York: McGraw-Hill, 1996; 59: 1476

    Google Scholar 

  45. Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 1990; 112(5): 352–64

    PubMed  CAS  Google Scholar 

  46. Mahoney J, Sager M, Dunham NC, et al. Risk of falls after hospital discharge. J Am Geriatr Soc 1994; 42: 269–74

    PubMed  CAS  Google Scholar 

  47. Eisman JA. OsteoPPPorosis-prevention, prevention and prevention. Aust N Z J Med 1991; 21: 205–9

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John H. Thwaites.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thwaites, J.H. Practical Aspects of Drug Treatment in Elderly Patients with Mobility Problems. Drugs Aging 14, 105–114 (1999). https://doi.org/10.2165/00002512-199914020-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-199914020-00003

Keywords

Navigation